Susquehanna International Group
PAVM icon

Susquehanna International Group’s PAVmed PAVM Stock Holding History

Susquehanna International Group’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,567
Closed -$317K – 13028
2023
Q4 		$317K Buy
2,567
+2,418
+1,623% +$285K ﹤0.01% 9712
2023
Q3 		$19.4K Sell
149
-17
-10% -$2.64K ﹤0.01% 11606
2023
Q2 		$30.5K Hold
166
– – ﹤0.01% 11511
2023
Q1 		$27.6K Buy
166
+9
+6% +$1.89K ﹤0.01% 11950
2022
Q4 		$33.9K Buy
157
+39
+33% +$14.7K ﹤0.01% 11583
2022
Q3 		$46K Buy
118
+30
+34% +$17K ﹤0.01% 12257
2022
Q2 		$37K Buy
88
+16
+22% +$7.73K ﹤0.01% 12132
2022
Q1 		$43K Sell
72
-66
-48% -$49K ﹤0.01% 12373
2021
Q4 		$153K Sell
138
-89
-39% -$193K ﹤0.01% 11765
2021
Q3 		$874K Buy
+227
New +$716K ﹤0.01% 7919
2021
Q2 		– Sell
-33
Closed -$66K – 13064
2021
Q1 		$66K Buy
+33
New +$49.6K ﹤0.01% 11981

Other funds holding PAVM

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's PAVM Position: Q1 2026 in Review

Susquehanna International Group sold out of PAVmed (PAVM) in Q1 2026, closing a stake of 2,274 shares — an estimated $15.1K sold.

Susquehanna International Group first reported a position in PAVM in Q1 2018 and held it in 14 quarters. The position peaked at $1.2M in Q1 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • Susquehanna International Group reported no remaining PAVmed position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 2,274 PAVmed shares in Q1 2026, an estimated $15.1K.
  • Susquehanna International Group first reported a position in PAVmed in Q1 2018 and held it in 14 quarters.
  • Susquehanna International Group's PAVmed position peaked at $1.2M in Q1 2021.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.